Hyperglycemia and Renin-Dependent Hypertension Synergize to Model Diabetic Nephropathy

Bryan R. Conway, Jillian Rennie, Matthew A. Bailey, Donald R. Dunbar, Jonathan Manning, Christopher O. Bellamy, Jeremy Hughes, John J. Mullins

Research output: Contribution to journalArticlepeer-review


Rodent models exhibit only the earliest features of human diabetic nephropathy, which limits our ability to investigate new therapies. Hypertension is a prerequisite for advanced diabetic nephropathy in humans, so its rarity in typical rodent models may partly explain their resistance to nephropathy. Here, we used the Cyp1 a1 mRen2 rat, in which the murine renin-2 gene is incorporated under the Cytochrome P4501 a1 promoter. In this transgenic strain, administration of low-dose dietary indole-3-carbinol induces moderate hypertension. In the absence of hypertension, streptozotocin-induced diabetes resulted in a 14-fold increase in albuminuria but only mild changes in histology and gene expression despite 28 weeks of marked hyperglycemia. In the presence of induced hypertension, hyperglycemia resulted in a 500-fold increase in albuminuria, marked glomerulosclerosis and tubulointerstitial fibrosis, and induction of many of the same pathways that are upregulated in the tubulointerstitium in human diabetic nephropathy. In conclusion, although induction of diabetes alone in rodents has limited utility to model human diabetic nephropathy, renin-dependent hypertension and hyperglycemia synergize to recapitulate many of the clinical, histological, and gene expression changes observed in humans.

Original languageEnglish
Pages (from-to)405-411
Number of pages7
JournalJournal of the American Society of Nephrology
Issue number3
Publication statusPublished - Mar 2012


Dive into the research topics of 'Hyperglycemia and Renin-Dependent Hypertension Synergize to Model Diabetic Nephropathy'. Together they form a unique fingerprint.

Cite this